These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 389495)

  • 21. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    Kinoshita T; Takata Y; Kozono H; Takeda J; Hong KS; Inoue K
    J Immunol; 1988 Dec; 141(11):3895-901. PubMed ID: 3183384
    [TBL] [Abstract][Full Text] [Related]  

  • 22. C3 dependent, C5 independent immune complex glomerulopathy in the mouse.
    Sawtell NM; Hartman AL; Weiss MA; Pesce AJ; Michael JG
    Lab Invest; 1988 Mar; 58(3):287-93. PubMed ID: 2964544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Activation of the alternative complement pathway by isolated human glomerular basement membrane.
    Williams JD; Czop JK; Abrahamson DR; Davies M; Austen KF
    J Immunol; 1984 Jul; 133(1):394-9. PubMed ID: 6373930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interactions of chrysotile asbestos fibres with the complement system.
    Saint-Remy JM; Cole P
    Immunology; 1980 Oct; 41(2):431-7. PubMed ID: 6904360
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Humoral immunostimulation. IV. Role of complement.
    Shearer WT; Atkinson JP; Frank MM; Parker CW
    J Exp Med; 1975 Apr; 141(4):736-52. PubMed ID: 1168690
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of classical pathway components during alternative pathway--modulated immune complex aggregation: the role of C1 INH.
    Gronski P; Bodenbender L; Kanzy EJ; Seiler FR
    Behring Inst Mitt; 1984 Nov; (76):29-41. PubMed ID: 6335396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstration of binding sites for IgG Fc and the third complement component (C3) on isolated hepatocytes.
    Hopf U; Meyer zum Büschenfelde KH; Dierich MP
    J Immunol; 1976 Aug; 117(2):639-45. PubMed ID: 781134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of extraglomerular renal damage in experimental chronic serum sickness. I. Histologic and immunofluorescence findings.
    Patrick CC; Virella G; McManus JF; Faulk WP; Hughson HD; Fudenberg HH
    Lab Invest; 1979 May; 40(5):603-14. PubMed ID: 374866
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A complement-resistant HeLa cell line (T638) is blocked at the step of C3 deposition.
    Santi P; Joiner KA; Hammer CH; Frank MM; Tosi R
    J Immunol; 1987 May; 138(10):3385-91. PubMed ID: 2952716
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of immune precipitation by purified components of the alternative pathway.
    Naama JK; Holme E; Hamilton E; Whaley K
    Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Localization of cationic proteins derived from platelets and polymorphonuclear neutrophils and local loss of anionic sites in glomeruli of rabbits with experimentally-induced acute serum sickness.
    Camussi G; Tetta C; Meroni M; Torri-Tarelli L; Roffinello C; Alberton A; Deregibus C; Sessa A
    Lab Invest; 1986 Jul; 55(1):56-62. PubMed ID: 3724064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Persistently circulating C3 nephritic factor (C3 NeF)-stabilized alternative pathway C3 convertase (C3 CoF) in serum of an 11-year-old girl with meningococcal septicemia--simultaneous occurrence with free C3 NeF.
    Wahn V; Müller W; Rieger C; Rother U
    Pediatr Res; 1987 Aug; 22(2):123-9. PubMed ID: 3658535
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The interaction of C5 with C3b in free solution: a sufficient condition for cleavage by a fluid phase C3/C5 convertase.
    Isenman DE; Podack ER; Cooper NR
    J Immunol; 1980 Jan; 124(1):326-31. PubMed ID: 7350230
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental immune glomerulonephritis induced in the rabbit with streptococcal vaccine.
    Bellon B; Kuhn J; Ayed K; Girard JF; Druet P
    Clin Exp Immunol; 1979 Aug; 37(2):239-46. PubMed ID: 387310
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Consumption of C3 via the classical and alternative complement pathways by sera and synovial fluids from patients with rheumatoid arthritis.
    Hunder GG; McDuffie FC; Clark RJ
    J Clin Lab Immunol; 1979 Nov; 2(4):269-73. PubMed ID: 119858
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro complement activation by rabbit lymphocytes and thymocytes in autologous serum.
    Wilson AB; Lachmann PJ; Coombs RR
    Immunology; 1979 May; 37(1):25-34. PubMed ID: 112041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Complement-mediated solubilization of immune complexes in immune complex nephritis].
    Amano T; Umakoshi Y; Kuwajima N; Mino Y; Takahashi K; Suzuki S; Ota Z; Huang S
    Nihon Jinzo Gakkai Shi; 1989 Aug; 31(8):807-13. PubMed ID: 2593317
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nephritic factor of the classical pathway of complement: immunoglobulin G autoantibody directed against the classical pathway C3 convetase enzyme.
    Halbwachs L; Leveillé M; Lesavre P; Wattel S; Leibowitch J
    J Clin Invest; 1980 Jun; 65(6):1249-56. PubMed ID: 6902727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement activation by pneumococci associated with acute otitis media.
    Prellner K
    Acta Pathol Microbiol Scand C; 1979 Jun; 87C(3):213-6. PubMed ID: 39420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The inhibitory effect of factor J on the alternative complement pathway.
    González-Rubio C; Jiménez-Clavero MA; Fontán G; López-Trascasa M
    J Biol Chem; 1994 Oct; 269(42):26017-24. PubMed ID: 7929312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.